Long-term patient-reported neurocognitive and functional outcomes after tick-borne encephalitis: a prospective controlled multicenter cohort study

OBJECTIVE: To characterize cognitive symptoms the first year after tick-borne encephalitis (TBE). METHODS: We conducted a controlled, multicenter cohort study of 109 hospitalized patients ≥16 years with confirmed TBE in Norway. At 3 and 12 months after admission, patients completed BRIEF-A (Global Executive Composite (GEC) and subscales), Everyday Memory Questionnaire-Revised (EMQ-R), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ), assessing executive functioning, memory, and post-TBE symptoms (higher scores indicate more difficulties). The primary outcomes were within-patient change in questionnaire scores from 3 to 12 months, and 12-month scores in patients compared to controls. The secondary outcomes were BRIEF-A subscale scores and proportion with clinically significant impairment. Covariates included in the analyses were age, sex, comorbidities, acute disease severity, anxiety, and depression. RESULTS: There were no significant changes from 3 to 12 months. At 12 months, scores were within the normal range, but patients had higher EMQ-R and RPQ than controls (p<0.001). BRIEF-A GECs did not differ, but patients had higher working memory subscale scores (p=0.002). These differences persisted after adjustment for anxiety and depression. Clinically significant impairment was more frequent in patients (odds ratios 2.29-8.19). Comorbidities, acute disease burden, anxiety, depression and female sex were associated with unfavorable 12 month outcome. CONCLUSION: TBE patients have an overall good one-year prognosis, but a minority-characterized by higher acute disease burden and comorbidities-have persistent cognitive difficulties that may warrant follow-up. Anxiety and depression were related to unfavorable prognosis but did not account for the cognitive differences between patients and controls. TRIAL REGISTRATION: Project #2,296,959-The NOrwegian Tick-borne Encephalitis Study-NOTES. An Observational Study on Clinical Features, Long-term Outcomes and Immune Characteristics-Cristin.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2026-08-27
DOI
https://doi.org/10.1007/s00415-026-14095-3
Primary Topic
Vector-borne infectious diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term patient-reported neurocognitive and functional outcomes after tick-borne encephalitis: a prospective controlled multicenter cohort study

Åslaug Rudjord Lorentzen, Jens Egeland, Hilde Skudal, Randi Eikeland et al.
Journal of Neurology
Vector-borne infectious diseases
article

Long-term patient-reported neurocognitive and functional outcomes after tick-borne encephalitis: a prospective controlled multicenter cohort study

Åslaug Rudjord Lorentzen, Jens Egeland, Hilde Skudal, Randi Eikeland, Tore Stenstad, Hege Kersten, Børre Fevang, Else Quist‐Paulsen, Malin Veje, Keson Jaioun
article en

Abstract

OBJECTIVE: To characterize cognitive symptoms the first year after tick-borne encephalitis (TBE). METHODS: We conducted a controlled, multicenter cohort study of 109 hospitalized patients ≥16 years with confirmed TBE in Norway. At 3 and 12 months after admission, patients completed BRIEF-A (Global Executive Composite (GEC) and subscales), Everyday Memory Questionnaire-Revised (EMQ-R), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ), assessing executive functioning, memory, and post-TBE symptoms (higher scores indicate more difficulties). The primary outcomes were within-patient change in questionnaire scores from 3 to 12 months, and 12-month scores in patients compared to controls. The secondary outcomes were BRIEF-A subscale scores and proportion with clinically significant impairment. Covariates included in the analyses were age, sex, comorbidities, acute disease severity, anxiety, and depression. RESULTS: There were no significant changes from 3 to 12 months. At 12 months, scores were within the normal range, but patients had higher EMQ-R and RPQ than controls (p<0.001). BRIEF-A GECs did not differ, but patients had higher working memory subscale scores (p=0.002). These differences persisted after adjustment for anxiety and depression. Clinically significant impairment was more frequent in patients (odds ratios 2.29-8.19). Comorbidities, acute disease burden, anxiety, depression and female sex were associated with unfavorable 12 month outcome. CONCLUSION: TBE patients have an overall good one-year prognosis, but a minority-characterized by higher acute disease burden and comorbidities-have persistent cognitive difficulties that may warrant follow-up. Anxiety and depression were related to unfavorable prognosis but did not account for the cognitive differences between patients and controls. TRIAL REGISTRATION: Project #2,296,959-The NOrwegian Tick-borne Encephalitis Study-NOTES. An Observational Study on Clinical Features, Long-term Outcomes and Immune Characteristics-Cristin.

Journal of NeurologyVol. 273(9)
Oslo University Hospital (NO), University of Oslo (NO), University of Agder (NO), Sahlgrenska University Hospital (SE), Sykehuset i Vestfold (NO), National Hospital (IN), Region Västra Götaland (SE), Telemark Hospital (NO), Institute for Biomedicine (IT), Sørlandet Sykehus (NO), University of Gothenburg (SE)
Sykehuset Telemark
Openalex Percentile: Top 9%
Vector-borne infectious diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.